Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Shenton

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2008
Impaired tamoxifen metabolism reduces survival in familial breast cancer patientsWilliam G Newman, Kristen D Hadfield, Ayshe Latif, et al.
European Journal of Human Genetics : EJHG|May 13, 2004
BRCA1/2 predictive testing: a study of uptake in two centresLucy Brooks, Fiona Lennard, Andrew Shenton, et al.
Journal of Medical Genetics|July 21, 2009
Breast cancer susceptibility variants alter risks in familial diseaseAyse Latif, Kristen D Hadfield, Stephen A Roberts, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 19, 2008
Better life expectancy in women with BRCA2 compared with BRCA1 mutations is attributable to lower frequency and later onset of ovarian cancerLouise M Byrd, Andrew Shenton, Eamonn R Maher, et al.
European Journal of Cancer (Oxford, England : 1990)|April 29, 2006
BRCA1, BRCA2 and TP53 mutations in very early-onset breast cancer with associated risks to relativesFiona Lalloo, Jennifer Varley, Anthony Moran, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 20, 2005
Screening for familial ovarian cancer: failure of current protocols to detect ovarian cancer at an early stage according to the international Federation of gynecology and obstetrics systemDiane Stirling, D Gareth R Evans, Gabriella Pichert, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2008
Impaired tamoxifen metabolism reduces survival in familial breast cancer patientsWilliam G Newman, Kristen D Hadfield, Ayshe Latif, et al.
European Journal of Human Genetics : EJHG|May 13, 2004
BRCA1/2 predictive testing: a study of uptake in two centresLucy Brooks, Fiona Lennard, Andrew Shenton, et al.
Journal of Medical Genetics|July 21, 2009
Breast cancer susceptibility variants alter risks in familial diseaseAyse Latif, Kristen D Hadfield, Stephen A Roberts, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 19, 2008
Better life expectancy in women with BRCA2 compared with BRCA1 mutations is attributable to lower frequency and later onset of ovarian cancerLouise M Byrd, Andrew Shenton, Eamonn R Maher, et al.
European Journal of Cancer (Oxford, England : 1990)|April 29, 2006
BRCA1, BRCA2 and TP53 mutations in very early-onset breast cancer with associated risks to relativesFiona Lalloo, Jennifer Varley, Anthony Moran, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 20, 2005
Screening for familial ovarian cancer: failure of current protocols to detect ovarian cancer at an early stage according to the international Federation of gynecology and obstetrics systemDiane Stirling, D Gareth R Evans, Gabriella Pichert, et al.
Pageof 2